Navigation Links
Raytheon to Provide California First Responders and Healthcare Personnel Electronic Patient Tracking System
Date:7/31/2009

LONG BEACH, Calif., July 31, 2009 /PRNewswire/ -- Raytheon Company (NYSE: RTN) will provide an electronic patient tracking system to a public health-led team of first responders and hospital personnel in Long Beach, Calif., that will improve the availability of patient information.

The EPTS, an information technology solution, facilitates the triage, treatment and transport of victims during mass casualty incidents by providing selected patient data to all involved parties, improving continuity of care and family notification response time.

"Raytheon has a long history of providing California first responders with open-standard communications solutions to improve efficiency and enhance community safety," said William Iannacci, director of Civil Communications Solutions for Raytheon. "Applying our systems integration expertise with our proven technology enables the California public safety community to more effectively share critical information."

The system uses a combination of barcode and radio frequency identification tags to identify the patient's location, medical status, and personal information. This information is wirelessly transferred to a secure Raytheon-hosted, Web-enabled database that provides the patient's information to hospitals and emergency personnel.

Upon arrival at one of the participating hospitals in Long Beach, a patient's status can be tracked to improve efficiency and ensure information accuracy. The system includes data interoperability tools and services provided by DropFire, Inc. This data will continue to be collected until the patient is admitted, released, or transferred to another hospital.

Raytheon Company, with 2008 sales of $23.2 billion, is a technology and innovation leader specializing in defense, homeland security and
'/>"/>

SOURCE Raytheon Company
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Raytheon Donates $100,000 to Fisher House Boston
2. BioCryst Reports Second Quarter 2009 Financial Results And Provides Corporate Update
3. Top-Five Global Pharmaceutical Company Names NewCardio as its Provider of Automated Thorough QT Solution
4. Prepaid Emergency Travel Announces a Unique Service That Provides Peace of Mind During Family Emergencies
5. Artificial Golgi may provide new insight into key cell structure
6. Indiana Drug Card to Provide Free Drug Cards to Residents
7. Humanitas Designated as Approved Provider by California Board of Registered Nursing for Continuing Education Course Credit and Units
8. Eucerin Provides BlogHer Attendees With a Glimpse Into Their Skins Future With Proprietary Time Machine Aging Simulator
9. Sunshine Heart Provides C-Pulse U.S. Clinical Update
10. Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2009 Second Quarter Financial Results
11. Delcath Systems Provides Update on Progress
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2010)... Slone Epidemiology Center have found a direct link ... 2 diabetes in African American women. The study, ... of Epidemiology , is the first prospective study ... and incidence of type 2 diabetes in a ... Type 2 diabetes is estimated to affect 20.6 ...
(Date:2/9/2010)... Montral, February 8, 2010- The research group of Dr. ... cliniques de Montral (IRCM), in collaboration with the team ... University of Toronto) accomplished a technical breakthrough: they mapped ... budding yeast Saccharomyces cerevisiae . The method used ... study has been published online today in the scientific ...
(Date:2/9/2010)... prematurely in the US, according to data presented by ... were reported at the 30th Annual Meeting of the ... published in the latest issue of the American ... that CP is associated with inflammation of the connective ... common in premature births from preterm labor and premature ...
(Date:2/9/2010)... The Quantum Foundation is proud to be partners ... Palm Beach County that will help kids and their ... Foundation (RWJF) recently announced a $360,000 grant to ... foods for children and families in Lake Worth , ... rigorous selection process that drew more than 500 proposals from ...
(Date:2/9/2010)... low-molecular-weight (LMW-E) forms of the protein cyclin E ... with estrogen-receptor-positive (ER+) breast cancers, researchers from The ... report in Clinical Cancer Research . , ... Keyomarsi, Ph.D., professor in M. D. Anderson,s Department ... and Olive Stringer Professor in Medical Oncology, found ...
Breaking Medicine News(10 mins):Health News:Neighborhood socioeconomic status and diabetes 2Health News:Researchers map all the fragile sites of the yeast Saccharomyces cerevisiae's genome 2Health News:Researchers map all the fragile sites of the yeast Saccharomyces cerevisiae's genome 3Health News:Incidence of cerebral palsy on rise in US 2Health News:Planting Seeds to Fight Childhood Obesity 2Health News:Low forms of cyclin E reduce breast cancer drug's effectiveness 2Health News:Low forms of cyclin E reduce breast cancer drug's effectiveness 3
... way of administration of drug that treats migraine.Giving migraine ... severe headaches without side effects. ,Dr. John Claude ... which included 85 patients who had experienced no relief ... valproate sodium every 5 minutes until their pain was ...
... The supreme court of India has declared that distribution ... profession is in nature of advertisement expenditure falling within ... of Income Tax Act. , The nature of the ... of the article in question. The public would not ...
... US study has found that women who have taken ... substantially greater risk of fatal ovarian cancer. ,The ... researchers from the American Cancer Society report// in the ... postmenopausal women from 1982 to 1996 and found ERT ...
... certain over-the-counter pain killers should carry warnings that ... ,The comments follow a study by Danish reseacher ... week's British Medical Journal which studied the effect ... like indomethacin (ibuprofen). ,Researchers used prescription //records ...
... British Medical Journal shows that bacteria with the ability to ... can be used successfully and may help reduce the use ... most common bacterial infections in young children, and is often ... the spread of Streptococcus pneumoniae and other bacteria from the ...
... that young women are much more likely to die following ... stereotype that men are more likely to die of heart ... week. ,Researchers from Emory, Yale and Massachusetts Universities followed ... hospital after a heart attack. They found that 28.9 per ...
Other Medicine News:
(Date:2/9/2010)... Feb. 9 LIVESTRONG Quarterly ... publication from LIVE STRONG .  The magazine features profiles ... resources and information about cancer prevention and treatment; and ... "As a three-time cancer survivor, I understand the worries ... said LIVE STRONG President and CEO Doug ...
(Date:2/9/2010)... Mass. , Feb. 9 Echo ... the needle-free Symphony™ tCGM System as a non-invasive, wireless, ... SkinPrep System for transdermal drug delivery, announced today that ... and CEO, will be interviewed on " Steve Crowley ... 9, 2010 at 9:34 AM ET ...
(Date:2/9/2010)... , Feb. 9 The rapid ... some shadow to the CRO and CMO businesses there. ... research and manufacturing organization that focuses on fine and ... advantages are not only low costs," said Dr. ... Shen continues: "What makes Chemphy so attractive to our ...
Breaking Medicine Technology:SPOT ON media and LIVESTRONG(R) Launch LIVESTRONG Quarterly 2SPOT ON media and LIVESTRONG(R) Launch LIVESTRONG Quarterly 3SPOT ON media and LIVESTRONG(R) Launch LIVESTRONG Quarterly 4Echo Therapeutics Chairman and CEO to be Interviewed on Steve Crowley's American Scene Radio Program and Featured on Money Channel Inc. 2Echo Therapeutics Chairman and CEO to be Interviewed on Steve Crowley's American Scene Radio Program and Featured on Money Channel Inc. 3Echo Therapeutics Chairman and CEO to be Interviewed on Steve Crowley's American Scene Radio Program and Featured on Money Channel Inc. 4DS Chemphy Focusing on CRO/CMO Business 2Pelosi Remarks at Democratic Steering and Policy Committee Forum on Health Insurance Reform 57234 1Pelosi Remarks at Democratic Steering and Policy Committee Forum on Health Insurance Reform 57234 2Pelosi Remarks at Democratic Steering and Policy Committee Forum on Health Insurance Reform 57234 3Sono Tek Announces its Largest Ever Sales of MediCoat Stent Coating Systems to a Leading Global Medical Device Manufacturer 57229 1Sono Tek Announces its Largest Ever Sales of MediCoat Stent Coating Systems to a Leading Global Medical Device Manufacturer 57229 2Disability Matters 3A Learn Your Rights Preserve Your Independence 57224 1Disability Matters 3A Learn Your Rights Preserve Your Independence 57224 2
... - Data Presented at 36th Child Neurology Society ... 11 PTC Therapeutics, Inc.,(PTC), a biopharmaceutical company ... drugs targeting,post-transcriptional control mechanisms, today announced pharmacokinetic,and safety ... PTC124 in patients with,Duchenne muscular dystrophy (DMD) due ...
... Conference Call Today at 9 am ET, ... NPSP ) today reported top-line results from,the ... GATTEX(TM),(teduglutide, recombinant GLP-2) in which 83 patients with ... of GATTEX, (0.05,milligrams/kilogram/day), a higher dose (0.10 mg/kg/day) ...
Other Medicine Technology:PTC Therapeutics Announces Pharmacokinetic and Safety Results from Phase 2 Study of PTC124 in Duchenne Muscular Dystrophy 2PTC Therapeutics Announces Pharmacokinetic and Safety Results from Phase 2 Study of PTC124 in Duchenne Muscular Dystrophy 3PTC Therapeutics Announces Pharmacokinetic and Safety Results from Phase 2 Study of PTC124 in Duchenne Muscular Dystrophy 4Clinical Benefits Demonstrated with Low-Dose GATTEX(TM) in Phase 3 Short Bowel Syndrome Study 2Clinical Benefits Demonstrated with Low-Dose GATTEX(TM) in Phase 3 Short Bowel Syndrome Study 3Clinical Benefits Demonstrated with Low-Dose GATTEX(TM) in Phase 3 Short Bowel Syndrome Study 4Clinical Benefits Demonstrated with Low-Dose GATTEX(TM) in Phase 3 Short Bowel Syndrome Study 5Clinical Benefits Demonstrated with Low-Dose GATTEX(TM) in Phase 3 Short Bowel Syndrome Study 6Clinical Benefits Demonstrated with Low-Dose GATTEX(TM) in Phase 3 Short Bowel Syndrome Study 7
Angled, pointed, with attached cable for Valleylab and other brands generators....
Autoclavable reusable pencil for Aaron 800 & 1200 - comes with generator or 1/box....
Split adult return electrode grounding pad with 2.8 m cable, 50/box....
Dissecting Forceps, straight, with RF-cable, 7" (18 cm). For use with all electrosurgical generators with standard three-prong sockets....
Medicine Products: